BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 16613497)

  • 1. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
    Karotki A; Khurana M; Lepock JR; Wilson BC
    Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-photon absorption cross section of excited phthalocyanines by a femtosecond Ti-sapphire laser.
    Mir Y; van Lier JE; Allard JF; Morris D; Houde D
    Photochem Photobiol Sci; 2009 Mar; 8(3):391-5. PubMed ID: 19255681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
    Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative in vitro demonstration of two-photon photodynamic therapy using photofrin and visudyne.
    Khurana M; Collins HA; Karotki A; Anderson HL; Cramb DT; Wilson BC
    Photochem Photobiol; 2007; 83(6):1441-8. PubMed ID: 18028219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
    Chang CJ; Yu JS; Wei FC
    Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.
    Mir Y; van Lier JE; Paquette B; Houde D
    Photochem Photobiol; 2008; 84(5):1182-6. PubMed ID: 18331397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
    Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy of age-related macular degeneration: History and principles.
    van den Bergh H
    Semin Ophthalmol; 2001 Dec; 16(4):181-200. PubMed ID: 15513440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
    Kinzler I; Haseroth E; Hauser C; Rück A
    Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.
    Usuda J; Hirata T; Ichinose S; Ishizumi T; Inoue T; Ohtani K; Maehara S; Yamada M; Tsutsui H; Okunaka T; Kato H; Ikeda N
    Int J Oncol; 2008 Oct; 33(4):689-96. PubMed ID: 18813781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells.
    Jiang F; Chopp M; Katakowski M; Cho KK; Yang X; Hochbaum N; Tong L; Mikkelsen T
    Lasers Med Sci; 2002; 17(4):280-8. PubMed ID: 12417983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy: an update.
    Dima VF; Vasiliu V; Dima SV
    Roum Arch Microbiol Immunol; 1998; 57(3-4):207-30. PubMed ID: 11845434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model.
    Jin I; Yuji M; Yoshinori N; Makoto K; Mikio M
    Arch Dermatol Res; 2008 Apr; 300(4):161-6. PubMed ID: 18080130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using white light during photodynamic therapy: visualization only or treatment?
    Mordon S; Maunoury V
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):765-71. PubMed ID: 16772834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question.
    Allison RR; Sibata CH
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericum perforatum L. extract - novel photosensitizer against human bladder cancer cells.
    Stavropoulos NE; Kim A; Nseyo UU; Tsimaris I; Chung TD; Miller TA; Redlak M; Nseyo UO; Skalkos D
    J Photochem Photobiol B; 2006 Jul; 84(1):64-9. PubMed ID: 16540336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
    Mitra S; Foster TH
    Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
    Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
    Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
    Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
    Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.